About a month after Merck, Pfizer alsoasked the FDAfor emergency use authorization for its pill, called Paxlovid.Pfizeris touting an89% reduction in the riskof hospitalization or death when its drug was given to high-risk patients within three days of their COVID-19 symptoms. The company, ...